Premarket Buzz: Achillion Pharmaceuticals (NASDAQ:ACHN), Apple Inc. (NASDAQ:AAPL), GoPro (NASDAQ:GPRO), Facebook Inc (NASDAQ:FB), Regulus Therapeutics Inc. (NASDAQ:RGLS)

Achillion Pharma (NASDAQ: ACHN) announced updated interim results from the ongoing interferon-free, ribavirin-free, Phase 2 study to evaluate the efficacy, safety, and tolerability of six weeks of 50 mg of ACH-3102 and 400 mg of sofosbuvir, a marketed nucleotide polymerase inhibitor, in treatment-na├»ve genotype 1 HCV-infected patients. On Friday shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) closed at $10.82. Company’s EPS growth for next 5 years is recorded as 17.58%.

Apple Inc. (NASDAQ:AAPL) is seeking to add to its recent run of blockbuster bond deals with a debut sale in Swiss francs, according to one of the banks arranging the offering. Goldman Sachs and Credit Suisse have been hired to manage the potential sale, which could come as soon as Tuesday, a banker said. Apple Inc. (NASDAQ:AAPL) in last trading activity decreased -0.84% to close at $118.93. Company weekly performance is 1.91% while its quarterly performance stands at 10.16%. Apple Inc. (NASDAQ:AAPL) is -1.08% away from its 52 week high.

Wearable camera manufacturer GoPro, Inc. (NASDAQ:GPRO) had a bumper end to 2014, shipping 2.4m of its devices in the final quarter of the year as its revenues soared. The company, which went public in June 2014, reported revenues of $633.9m in the fourth quarter of 2014, a 75% year-on-year rise from its $361.5m of sales in the final quarter of 2013. On last trading day GoPro, Inc. (NASDAQ:GPRO) decreased -13.33% to close at $47.12. Its volatility for the week is 6.45% while volatility for the month is 6.93%. GoPro, Inc. (NASDAQ:GPRO) monthly performance is -24.55%.

Facebook Inc (NASDAQ:FB) has already changed how people connect online. Now it’s thinking about transforming the Silicon Valley tech campus. On Friday, the world’s largest social media company acquired a 56-acre industrial park immediately south of its current Menlo Park, California, headquarters from Prologis Inc., the international warehousing company formerly based in Denver, the Silicon Valley Business Journal reports exclusively. Facebook Inc (NASDAQ:FB) has 0.30% insider ownership while its institutional ownership stands at 63.70%. In last trading activity company’s stock closed at $74.47.

Regulus Therapeutics Inc. (NASDAQ: RGLS), announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 (“miR-122”), for the treatment of hepatitis C virus infection (“HCV”). On last trading day Regulus Therapeutics Inc. (NASDAQ:RGLS) decreased -2.15% to close at $16.86. Its volatility for the week is 8.68% while volatility for the month is 8.04%. Regulus Therapeutics Inc. (NASDAQ:RGLS) monthly performance is -1.29%.

Leave a Reply

Your email address will not be published. Required fields are marked *